Register entry
- Registered sites
- 0
- Active NDC listings
- 2
- Live patents
- 5
- Exclusivities
- 1
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 2 human prescription drug. By marketing category: NDA 2.
| Dosage form | NDCs |
|---|---|
| spray | 1 |
| suspension | 1 |
| Route | NDCs |
|---|---|
| nasal | 1 |
| oral | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| scienture llc | 2 |
Exclusivity
Patents and exclusivities
5| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 12514854 | REZENOPYnaloxone hydrochloride | use | Feb 2041 |
| 12622903 | REZENOPYnaloxone hydrochloride | product | Feb 2041 |
| 11890273 | ARBLIlosartan potassium | product | Oct 2041 |
| 12156869 | ARBLIlosartan potassium | product | Oct 2041 |
| 12605365 | ARBLIlosartan potassium | product | Oct 2041 |
| Product | Exclusivity | Until |
|---|---|---|
| REZENOPYNALOXONE HYDROCHLORIDE | NP New product | Apr 2027 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| ARBLI | losartan potassium | suspension, oral | 83245-053NDA |
| REZENOPY | naloxone HCl | spray, nasal | 83245-003NDA |
Compare
Other companies listing losartan potassium
- Organon LLC4 sites · 95 NDC
- Bryant Ranch Prepack1 site · 4,357 NDC
- Proficient Rx LP1 site · 1,729 NDC
- Coupler LLC1 site · 469 NDC
- Jubilant Cadista Pharmaceuticals Inc.0 sites · 48 NDC
Enquiry
Common questions
- Is Scienture LLC FDA approved?
- Scienture LLC holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Scienture LLC make?
- 2 products are listed under Scienture LLC in the openFDA NDC Directory, most often as spray; suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.